Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm (BladParadigm)

NCT05779631 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05779631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05779631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm (BladParadigm)
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
December 6, 2023
Completion date
June 30, 2031
Enrollment
360 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, muscle-invasive bladder cancer